Skip to main content

Animations

MJFF Publications

231 - 240 of 8404 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    RESTRICTED
    Title: Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf003
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30111
    Citation Count: 0
  • Summary Details
    OPEN
    Title: N2GNet tracks gait performance from subthalamic neural signals in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01364-6
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adn1927
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Fox Insight: Most Bothersome Symptoms in Early‐Stage Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14321
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00848-2
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: 14–3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106801
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Disease-Modifying Therapies in Parkinson’s Disease
    Journal Name: Neurologic Clinics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ncl.2024.12.009
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf066
    Best OA location URL:
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.